Objectives: To assess the efficacy and safety of rituximab for multiple sclerosis (MS)
treatment in terms of reduction in clinical relapses, magnetic resonance imaging (MRI) …

Background Rituximab is increasingly being used in treatment of multiple Sclerosis (MS) in
our centers due to its easy availability, efficacy and favorable side effect profile. Here we …

Objective. To evaluate the efficacy and safety of rituximab in multiple sclerosis in a clinical
practice setting. Methods. Clinical data for all adult patients with multiple sclerosis (MS) …

Introduction: Rituximab (RTX) showed to be effective and relatively safe in the treatment of
relapsing-remitting and progressive forms of multiple sclerosis (MS), both in the phase II …

Introduction Rituximab is considered as a potential therapeutic option in relapsing-remitting
(RRMS) and progressive forms (PMS) of multiple sclerosis (MS). Objective To investigate the …

Objective We aimed to synthesize all available observational studies and clinical trials of
rituximab to estimate the safety and efficacy of this monoclonal antibody in people with …

Background Multiple sclerosis (MS) is an autoimmune, neuroinflammatory, and
neurodegenerative disease of the central nervous system. B cells have recently emerged as …

Background Multiple sclerosis (MS) is an inflammatory demyelinating condition of the central
nervous system that leads to neurological disability and a poor quality of life (QoL) …

Introduction Rituximab (RTX) is considered a potential therapeutic option for relapsing-
remitting (RRMS) and progressive forms (PMS) of multiple sclerosis (MS). The main …

Objective: The objective of this study was to evaluate the efficacy and safety of rituximab
(RTX) treatment given off-label to Cypriot patients with multiple sclerosis (MS). Methods …